August 22, 2016August 22, 2016

FDA Grants Orphan Drug Status to Pulmatrix’s PUR1900 for Cystic Fibrosis Fungal Lung Infections

Cystic Fibrosis, News

The U.S. Food & Drug Administration (FDA) has granted orphan drug designation to Pulmatrix‘s PUR1900, an inhaled drug for the treatment of pulmonary fungal infections in patients with cystic fibrosis (CF). ... Read more

September 1, 2014November 5, 2015

Study Warns Cystic Fibrosis Patients to Avoid Aspergillus Exposure

Cystic Fibrosis, News

Today’s U.S. health and disease statistics from public health authorities such as the Center for Disease Control reveal that approximately 30,000 Americans are living with cystic fibrosis (CF), a hereditary, ... Read more